Skip to content

nvestigate the effect of fluoxetine and Citalopram on motor performance after stroke in acute stroke patients

Investigate the effect of fluoxetine and Citalopram on motor performance after stroke in acute stroke patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220810055657N1
Enrollment
90
Registered
2022-09-03
Start date
2022-03-21
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute stroke. Cerebral infarction, unspecified

Interventions

Intervention 1: Control group: Participants will receive capsules containing microcrystalline cellulose as a placebo orally once a day for 90 days along with physical therapy one hour a day, 5 days a

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Over 18 years old motor or sensory paralysis of half of the body following the first episode of acute stroke (within the last 24 hours), cerebral ischemia Vogel-Meyer motor score below 55

Exclusion criteria

Exclusion criteria: Age over 70 years National Institute of Health stroke score above 15 Previous disabilities include: lack of speech, cognitive and movement disorders caused by stroke or any disease of the cerebral cortex. Pregnancy or breastfeeding Current use of antidepressants Kidney failure (glomerular filtration rate below 30 ml per minute) Abnormal liver function tests Hyponatremia and long TQ interval in heart strip Restlessness, increased pressure or other manifestations of serotonin syndrome (after starting treatment)

Design outcomes

Primary

MeasureTime frame
Motor function after acute stroke in patients. Timepoint: On the 90th day from the beginning of the study. Method of measurement: Fugl-Meyer movement scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Vahid Dehghani

Kashan University of Medical Sciences

dehghani-v@kaums.ac.ir55443022-031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026